TY - JOUR AU - Worobec SM AB -

This review surveys current treatments and future treatment trends in leprosy from a clinical perspective. The World Health Organization provides a multidrug treatment regimen that targets the bacillus which causes leprosy. Several investigational drugs are available for the treatment of drug-resistant . Future directions in leprosy treatment will focus on: the molecular signaling mechanism uses to avoid triggering an immune response; prospective studies of the side effects experienced during multiple-drug therapy; recognition of relapse rates post-completion of designated treatments; combating multidrug resistance; vaccine development; development of new diagnostic tests; and the implications of the recent discovery of a genetically distinct leprosy-causing bacillus, .

BT - Research and reports in tropical medicine C1 -

http://www.ncbi.nlm.nih.gov/pubmed/30100775?dopt=Abstract

DO - 10.2147/RRTM.S27395 J2 - Res Rep Trop Med LA - eng N2 -

This review surveys current treatments and future treatment trends in leprosy from a clinical perspective. The World Health Organization provides a multidrug treatment regimen that targets the bacillus which causes leprosy. Several investigational drugs are available for the treatment of drug-resistant . Future directions in leprosy treatment will focus on: the molecular signaling mechanism uses to avoid triggering an immune response; prospective studies of the side effects experienced during multiple-drug therapy; recognition of relapse rates post-completion of designated treatments; combating multidrug resistance; vaccine development; development of new diagnostic tests; and the implications of the recent discovery of a genetically distinct leprosy-causing bacillus, .

PY - 2012 SP - 79 EP - 91 T2 - Research and reports in tropical medicine TI - Current approaches and future directions in the treatment of leprosy. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067781/pdf/rrtm-3-079.pdf VL - 3 SN - 1179-7282 ER -